PNN and KRT19

Number of citations of the paper that reports this interaction (PMID 10809736)
6

Data Source:
HPRD (in vitro, two hybrid)

		PNN	KRT19
Gene Name		pinin, desmosome associated protein	keratin 19, type I
Image		No pdb structure	No pdb structure
Gene Ontology Annotations	Cellular Component	Nucleoplasm Cytoplasm Intermediate Filament Plasma Membrane Cell-cell Junction Membrane Nuclear Speck Desmosome Exon-exon Junction Complex Catalytic Step 2 Spliceosome	Intermediate Filament Dystrophin-associated Glycoprotein Complex Z Disc Sarcolemma Costamere Extracellular Vesicular Exosome Cell Periphery
	Molecular Function	DNA Binding Structural Molecule Activity Poly(A) RNA Binding	Structural Constituent Of Cytoskeleton Protein Binding Structural Constituent Of Muscle Protein Complex Binding
	Biological Process	MRNA Splicing, Via Spliceosome Transcription, DNA-templated Regulation Of Transcription, DNA-templated Cell Adhesion	Viral Process Response To Estrogen Sarcomere Organization Cell Differentiation Involved In Embryonic Placenta Development
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions		16 interactors: CNGB1 CSNK2A1 CTBP1 CTBP2 DYNC1I2 KRT18 KRT19 KRT8 PNISR PPIG PRPF4B RNPS1 SRRM2 SRSF4 YWHAG ZCCHC17	37 interactors: ABI2 AMOTL2 APC C10orf10 C1orf109 CARD9 CCDC146 CEP57L1 DGCR6L DMD EIF4E2 EIF4ENIF1 EXOC8 FAM107A FAM124B FANCG HAUS1 HGS IKZF3 KDM1A KIFC3 KRT15 KRT2 KRT6B PCM1 PLEKHA5 PNN POLR1C PPP1R18 SFI1 TBC1D7 TFPT TUBG1 UBE2I UCHL5 USHBP1 ZNF638
Entrez ID		5411	3880
HPRD ID		04401	01007
Ensembl ID		ENSG00000100941	ENSG00000171345
Uniprot IDs		Q9H307	P08727
PDB IDs
Enriched GO Terms of Interacting Partners?		Viral Process RNA Splicing MRNA Splicing, Via Spliceosome RNA Splicing, Via Transesterification Reactions RNA Processing Hepatocyte Apoptotic Process Negative Regulation Of MRNA Splicing, Via Spliceosome White Fat Cell Differentiation Negative Regulation Of RNA Splicing MRNA Processing Viral Genome Replication RNA Metabolic Process Cell Differentiation Involved In Embryonic Placenta Development Tumor Necrosis Factor-mediated Signaling Pathway MRNA Metabolic Process Termination Of RNA Polymerase II Transcription Gene Expression Sarcomere Organization Golgi To Plasma Membrane CFTR Protein Transport Negative Regulation Of Transcription From RNA Polymerase II Promoter By Histone Modification Regulation Of MRNA Splicing, Via Spliceosome MRNA Export From Nucleus Negative Regulation Of Cellular Metabolic Process DNA-templated Transcription, Termination RNA Export From Nucleus Myofibril Assembly Apoptotic Signaling Pathway Organelle Organization MRNA 3'-end Processing Regulation Of MRNA Processing Negative Regulation Of Chromosome Organization Cellular Response To Tumor Necrosis Factor Cell Differentiation Regulation Of RNA Splicing Extrinsic Apoptotic Signaling Pathway RNA 3'-end Processing Nucleobase-containing Compound Metabolic Process Actomyosin Structure Organization Apoptotic Process Embryonic Placenta Development G2/M Transition Of Mitotic Cell Cycle Nuclear Export MRNA Transport Programmed Cell Death Heterocycle Metabolic Process Cellular Aromatic Compound Metabolic Process Response To Tumor Necrosis Factor Fat Cell Differentiation Cell Death Death	Cytoplasmic Microtubule Organization Organelle Organization Mitotic Cell Cycle Process Microtubule Cytoskeleton Organization Cell Cycle Process Mitotic Cell Cycle Microtubule-based Process Mitotic Cell Cycle Phase Transition Cell Cycle Phase Transition G2/M Transition Of Mitotic Cell Cycle Muscle Cell Cellular Homeostasis Cell Cycle Keratinocyte Activation Regulation Of Primitive Erythrocyte Differentiation Positive Regulation Of SUMO Transferase Activity Exocyst Assembly Microtubule Anchoring Nucleus Localization Negative Regulation Of Intracellular Signal Transduction Cytoskeleton Organization
Tagcloud ?		accordingly aforementioned ann arrangement artificial axillary carry categorized dissection drop indication input leaving lymph marker markers necessity network nodal node nodes obviate oestrogen output pr predication prediction probabilistic tumour	allograft biomarkers changed chronic clu cr diagnose differential difficult itraq latter lcn2 liver maldi olt option orthotopic predicting quantified re rejection reliable relt sixty tof transplantation treat understand unfortunately
Tagcloud (Difference) ?		accordingly aforementioned ann arrangement artificial axillary carry categorized dissection drop indication input leaving lymph marker markers necessity network nodal node nodes obviate oestrogen output pr predication prediction probabilistic tumour	allograft biomarkers changed chronic clu cr diagnose differential difficult itraq latter lcn2 liver maldi olt option orthotopic predicting quantified re rejection reliable relt sixty tof transplantation treat understand unfortunately
Tagcloud (Intersection) ?